Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.49 |
| ▸ | MMP8 | P22894 | 1/20 | 0.49 |
| ▸ | MMP14 | P50281 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.37 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.34 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3343020 | 0.94 | CYP3A4 (0.64) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL9012207 | 0.92 | CYP3A4 (0.56) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL3412198 | 0.90 | CYP3A4 (0.68) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL6937187 | 0.89 | CYP3A4 (0.66) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL1835296 | 0.87 | CYP3A4 (0.74) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL5826164 | 0.87 | CYP3A4 (0.64) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL8457151 | 0.87 | CYP3A4 (0.64) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL6939839 | 0.87 | CYP3A4 (0.64) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| SCHEMBL3776584 | 0.86 | CYP3A4 (0.62) | CYP3A4ALDH1A1MMP9MMP8MMP14 | |
| Ethylene SCHEMBL15254964 | 0.86 | CYP3A4 (0.67) | CYP3A4ALDH1A1MMP9MMP8MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 445 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107207700-B | Method for synthesizing polyoxazolidone compound with high stability | 科思创德国股份有限公司 | 2021-04-27 | — | — | CN | claimed |
| CN-112341391-A | Naphthalimide organic dye, electrowetting display ink and electrowetting display | 深圳市国华光电科技有限公司 | 2021-02-09 | — | — | CN | claimed |
| US-20200048189-A1 | GUANIDINE CATALYST FOR CURABLE COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2020-02-13 | — | — | US | claimed |
| EP-3601217-A1 | GUANIDINE CATALYST FOR CURABLE COMPOSITIONS | Sika Technology AG (CH) | 2020-02-05 | — | — | EP | claimed |
| US-10385167-B2 | Process for the synthesis of polyoxazolidinone compounds with high stability | COVESTRO DEUTSCHLAND AG (DE) | 2019-08-20 | — | — | US | claimed |
| EP-3256508-B1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2019-03-27 | — | — | EP | claimed |
| WO-2018172168-A1 | GUANIDINE CATALYST FOR CURABLE COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2018-09-27 | — | — | WO | claimed |
| US-20180022871-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2018-01-25 | — | — | US | claimed |
| EP-3256508-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | Covestro Deutschland AG (DE) | 2017-12-20 | — | — | EP | claimed |
| WO-2016128380-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2016-08-18 | — | — | WO | claimed |
| EP-0006122-B1 | PROCESS FOR BATCH-COLOURING HARD PVC AND POLYOLEFINES | CIBA-GEIGY AG (CH) | 1982-04-28 | — | — | EP | claimed |
| US-4315756-A | Oil-soluble azo dye with N-substituted β-naphthylamine as coupling component | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | claimed |
| US-4315855-A | Monoazo disperse dyes containing a nitrophenyl group and a homophthalimide group | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | claimed |
| US-4294620-A | Phthalocyanine formulations | BASF AKTIENGESELLSCHAFT (DE) | 1981-10-13 | — | — | US | claimed |
| US-4255203-A | COMPRISING AN ORGANIC PIGMENT AND AN ARYL BISUREA DERIVATIVE; PRINTING INKS; PAINTS; GLOSS; COLOR INTENSITY, AND FLUID FLOW | BASF AKTIENGESELLSCHAFT (DE) | 1981-03-10 | — | — | US | claimed |
| US-4238386-A | Process for the mass pigmenting of rigid polyvinyl chloride and polyolefins | CIBA-GEIGY CORPORATION (US) | 1980-12-09 | — | — | US | claimed |
| US-4097605-A | Alkyl thiourea miticides | STAUFFER CHEMICAL COMPANY (US) | 1978-06-27 | — | — | US | claimed |
| US-4000985-A | DISAZO | MORTON-NORWICH PRODUCTS, INC. (US) | 1977-01-04 | — | — | US | claimed |
| US-3997464-A | 1-HYDROXY-4-(P-TOLUIDINO)-9,10-ANTHRAQUINONE, A COPPER PHTHALOCYANINE TRISULFONAMIDE, UV ABSORBER | AMERICAN CYANAMID COMPANY (US) | 1976-12-14 | — | — | US | claimed |
| US-3946017-A | PRESSURE SENSITIVE MATERIALS | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1976-03-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048189-A1 | GUANIDINE CATALYST FOR CURABLE COMPOSITIONS | GMPS, GMNN, GUCY1A1 | CYP3A4 3137/4885ALDH1A1 805/4885MMP9 656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.